| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/1999 | EP0913480A2 Chorismate synthase |
| 05/06/1999 | EP0913479A2 Adenine glycosylase |
| 05/06/1999 | EP0913478A2 Histidine kinase from Streptococcus pneumoniae 0100993 |
| 05/06/1999 | EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase |
| 05/06/1999 | EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof |
| 05/06/1999 | EP0913474A2 Dbpa, a helicase from Staphylococcus aureus |
| 05/06/1999 | EP0913472A2 Human LIG-1 Homolog (HLIG-1) |
| 05/06/1999 | EP0913471A2 Cdna clone HNEAA81 that encodes a human 7-transmembrane receptor |
| 05/06/1999 | EP0913470A2 The human C3b/C4b receptor (CR1) |
| 05/06/1999 | EP0913404A1 Differentiation inhibitor |
| 05/06/1999 | EP0913156A1 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 05/06/1999 | EP0912898A2 Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg |
| 05/06/1999 | EP0912763A1 Novel anti-hiv ribozymes |
| 05/06/1999 | EP0912747A1 Aspartic protease |
| 05/06/1999 | EP0912742A1 Viral interleukin-6 |
| 05/06/1999 | EP0912741A2 T-cell selective interleukin-4 agonists |
| 05/06/1999 | EP0912740A1 Rantes homolog from prostate |
| 05/06/1999 | EP0912739A2 Canine ob protein compositions and methods |
| 05/06/1999 | EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/06/1999 | EP0912735A2 Secreted proteins and polynucleotides encoding them |
| 05/06/1999 | EP0912734A1 Chimeric heteromultimer adhesins |
| 05/06/1999 | EP0912731A2 Secreted proteins |
| 05/06/1999 | EP0912730A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 05/06/1999 | EP0912729A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 05/06/1999 | EP0912728A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces |
| 05/06/1999 | EP0912612A1 Simplified production of bispecific antibody fragments |
| 05/06/1999 | EP0912611A1 Human monoclonal antibodies to the hepatitis b surface antigen |
| 05/06/1999 | EP0912609A2 Fragments of leptin (ob protein) |
| 05/06/1999 | EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines |
| 05/06/1999 | EP0912607A2 Vaccines comprising synthetic genes |
| 05/06/1999 | EP0912602A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 05/06/1999 | EP0912601A1 Suppression of immune response via inhibition of cathepsin s |
| 05/06/1999 | EP0912600A2 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 05/06/1999 | EP0912595A1 Hodgkin's disease associated molecules and uses thereof |
| 05/06/1999 | EP0912204A2 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier |
| 05/06/1999 | EP0912198A1 Immunoliposomes that optimize internalization into target cells |
| 05/06/1999 | EP0912197A2 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 05/06/1999 | EP0912196A1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 05/06/1999 | EP0912192A1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors |
| 05/06/1999 | EP0912187A2 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts |
| 05/06/1999 | EP0912181A1 Appetite suppression |
| 05/06/1999 | EP0912157A1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 05/06/1999 | EP0912097A1 Antimicrobial peroxidase compositions |
| 05/06/1999 | EP0785792B1 Treatment of ovarian estrogen dependent conditions |
| 05/06/1999 | EP0746333B1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
| 05/06/1999 | EP0742721B1 Methods of prolonged suppression of humoral immunity |
| 05/06/1999 | EP0688327B1 Analogs for specific oligosaccharide-protein interactions and uses therefor |
| 05/06/1999 | EP0688315B1 Pyrrolidine and oxazolidine derivatives, their preparation and their use as inhibitors of thrombocyte aggregation |
| 05/06/1999 | EP0680333B1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 05/06/1999 | EP0654272B1 Alimentary canal cell activator |
| 05/06/1999 | EP0624199B1 Methods for producing thrombin |
| 05/06/1999 | EP0576439B1 Monoclonal antibody against lps core |
| 05/06/1999 | EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 05/06/1999 | EP0563060B1 Use of IL-4 and TNF for the preparation of a medicament for the treatment of tumour cells |
| 05/06/1999 | EP0541692B1 Herpes simplex virus vp16 vaccines |
| 05/06/1999 | DE19751637A1 Antitumor medicament containing interleukin II, N-acetyl-cysteine and selenium has T-lymphocyte cytotoxicity stimulating activity |
| 05/06/1999 | DE19748763A1 Verwendung von Vasopressin-Antagonisten Use of vasopressin antagonists |
| 05/06/1999 | DE19747718A1 Use of gene therapy |
| 05/06/1999 | CA2308705A1 Aggregates of human insulin derivatives |
| 05/06/1999 | CA2308511A1 Use of transfected or transduced mammalian cells for treating bone pathologies |
| 05/06/1999 | CA2308463A1 Cd8 as an inhibitor of the cellular immune system |
| 05/06/1999 | CA2308115A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 05/06/1999 | CA2308102A1 New nucleotide sequences |
| 05/06/1999 | CA2307953A1 Gene therapy for stimulation of angiogenesis |
| 05/06/1999 | CA2307830A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 05/06/1999 | CA2307826A1 Enhancement of morphogen activity |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2307178A1 Soluble mhc complexes and methods of use thereof |
| 05/06/1999 | CA2307014A1 Viral encoded semaphorin protein receptor dna and polypeptides |
| 05/06/1999 | CA2306905A1 Fatty acid-acylated insulin analogs |
| 05/06/1999 | CA2306877A1 Insoluble insulin compositions |
| 05/06/1999 | CA2306790A1 Application of tnf antagonists as medicaments for treating septic diseases |
| 05/06/1999 | CA2306754A1 Histogranin peptide and their analgesic use |
| 05/06/1999 | CA2306183A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 05/06/1999 | CA2252999A1 Novel rncs |
| 05/05/1999 | CN1216063A IL-6 mutein |
| 05/05/1999 | CN1216047A Antifungic and antibaterial peptide |
| 05/05/1999 | CN1215994A Rnase L activators and antisense oligonucleotides effective to treat RSV infections |
| 05/05/1999 | CN1215991A Enteric-coated pharmaceutical compositions of mycophenolate |
| 05/05/1999 | CN1215752A Health wine |
| 05/05/1999 | CN1043189C Method for preparing prolonged release preparation |
| 05/04/1999 | US5901069 System, method, and computer program product for at least partially automatically generating chemical compounds with desired properties from a list of potential chemical compounds to synthesize |
| 05/04/1999 | US5900477 Use of hemoglobin in the treatment of hemorrhagic shock |
| 05/04/1999 | US5900476 Mutant polypeptide without cysteines, or modified to prevent disulfide bond formation suppresses binding of factor to platelets; antithrombosis agents |
| 05/04/1999 | US5900413 Administering with amoxicillin |
| 05/04/1999 | US5900409 Cerebration improver |
| 05/04/1999 | US5900404 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 05/04/1999 | US5900403 Use of iron hemoprotein for treating pathogenic syndrome caused by nitric oxide overproduction |
| 05/04/1999 | US5900402 Reacting an oxygen-carrying protein (e.g., hemoglobin) with a substantially non-antigenic polymer and administering the conjugate to a mammal |
| 05/04/1999 | US5900401 Remedy for respiratory-tract viral disease |
| 05/04/1999 | US5900400 Protein |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 05/04/1999 | US5900237 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 05/04/1999 | US5900235 Polypeptides |
| 05/04/1999 | CA2180424C Drugs, vaccines and hormones in polylactide coated microspheres |
| 05/04/1999 | CA2129637C Treatment for inflammatory bowel disease |
| 05/04/1999 | CA2037333C Dna encoding a major mite allergen and the use thereof |
| 05/04/1999 | CA1340530C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
| 05/04/1999 | CA1340522C Fusion proteins containing neighbouring histidines for improved purification |
| 05/04/1999 | CA1340520C Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix |